Related Experiment Video
Updated: May 23, 2026
08:00
Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells
Published on: January 12, 2015
Pluripotent stem cell-based heart regeneration: from the developmental and immunological perspectives
Kathy O Lui1, Lei Bu, Ronald A Li
1Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School and Harvard Stem Cell Institute, Boston, Massachusetts 02114, USA.
Birth Defects Research. Part C, Embryo Today : Reviews
|March 30, 2012
Summary
Human hearts cannot regenerate cardiomyocytes after injury. This review explores using cardiac progenitor cells and pluripotent stem cells for heart repair, focusing on paracrine factors and immunogenicity for better cell therapy outcomes.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Stem Cell Therapy
Background:
- Myocardial infarction leads to significant cardiomyocyte loss, and the adult mammalian heart has limited regenerative capacity.
- Epicardial progenitors, quiescent in uninjured hearts, proliferate and differentiate after myocardial infarction.
- Human pluripotent stem cells can differentiate into cardiomyocytes, smooth muscle, and endothelial cells.
Purpose of the Study:
- To review the therapeutic potential and challenges of using pluripotent stem cells and progenitor cells for myocardial repair.
- To highlight the role of paracrine factors in myocardial growth and neovascularization.
- To discuss the impact of immunogenicity on cell survival and engraftment in cell therapy.
Main Methods:
- Review of current literature on cardiac progenitor cells and pluripotent stem cells.
- Analysis of mechanisms underlying myocardial regeneration and neovascularization.
- Evaluation of immunologic factors affecting cell therapy efficacy.
Main Results:
- Epicardial progenitors offer a potential source for cardiac cell therapy after myocardial infarction.
- Pluripotent stem cells can generate essential cardiac cell types.
- Paracrine factors and immunogenicity are critical determinants of therapeutic success.
Conclusions:
- Targeting endogenous cardiac progenitors and utilizing pluripotent stem cells show promise for heart repair strategies.
- Understanding paracrine signaling and immune responses is crucial for advancing cell-based cardiac therapies.
Related Concept Videos
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.